Search clinical trials for: Immediate release carbidopa/levodopa
Total 412 results
-
UCB PharmaCompleted
-
University of RochesterTerminated
-
AstraZenecaCompleted
-
Impax Laboratories, LLCCompletedParkinson's Disease (Disorder)United States, Czechia, France, Italy, Spain, Germany, Poland, United Kingdom
-
LobSor Pharmaceuticals ABTFS Trial Form SupportCompleted
-
University of MinnesotaCompletedKidney Transplant Failure and RejectionUnited States
-
Azurity PharmaceuticalsCompletedAbuse PotentialUnited States
-
Acorda TherapeuticsCompleted
-
GlaxoSmithKlineCompletedParkinson DiseaseSpain, France, Bulgaria, United Kingdom, Germany, Hungary, Russian Federation, South Africa, Italy, Canada, Czechia, Poland, Romania, Ukraine
-
Diurnal LimitedCompletedCongenital Adrenal HyperplasiaFrance, United States, Japan
-
Galderma R&DCompletedPapulopustular RosaceaUnited States
-
Mundipharma Research LimitedTerminatedPolymyalgia RheumaticaUnited Kingdom
-
Dinora, Inc.PharPoint Research, Inc.; Analgesic SolutionsTerminated
-
Maastricht University Medical CenterCompletedDopamine Activity | Episodic Memory Consolidation | Response PreparationNetherlands
-
Boehringer IngelheimCompleted
-
Diurnal LimitedNational Institutes of Health Clinical Center (CC)CompletedAdrenogenital Syndrome | Congenital Adrenal Hyperplasia | 21-Hydroxylase DeficiencyUnited States
-
Bial - Portela C S.A.Completed
-
University of California, Los AngelesCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Botswana, Germany, South Africa
-
PfizerCompletedHealthy ParticipantsBelgium
-
Impax Laboratories, LLCMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson's DiseaseUnited States
-
Boehringer IngelheimCompleted
-
PfizerCompletedHealthy ParticipantsBelgium
-
Royal Victoria Hospital, CanadaNot yet recruitingModerate to Severe Opioid Use DisorderCanada
-
Boehringer IngelheimCompleted
-
Cedars-Sinai Medical CenterVeloxis PharmaceuticalsActive, not recruitingKidney Transplant RejectionUnited States
-
Boehringer IngelheimCompletedParkinson DiseaseFrance, Germany, Netherlands
-
Horizon Pharma Ireland, Ltd., Dublin IrelandCompleted
-
Boehringer IngelheimCompleted
-
Milton S. Hershey Medical CenterPfizerCompleted
-
Aarhus University HospitalUniversity of CopenhagenUnknownParkinson´s DiseaseDenmark
-
Sarfez Pharmaceuticals, Inc.Sarfez Pharmaceuticals, Inc.Recruiting
-
University of PennsylvaniaCompletedHealthy VolunteersUnited States
-
University of British ColumbiaPaladin Labs Inc.RecruitingLiver Transplantation | Neurotoxicity | Tremor | Tacrolimus | ImmunosuppressionCanada
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of YM178Netherlands
-
Boehringer IngelheimCompletedParkinson DiseaseAustria, Czech Republic, Hungary, India, Italy, Korea, Republic of, Philippines, Poland, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
-
Galderma R&DCompletedRosaceaUnited States, Canada, Hungary
-
Boehringer IngelheimCompletedEarly Parkinson Disease (Early PD)United States, Argentina, Austria, Czech Republic, Finland, Germany, Hungary, India, Japan, Malaysia, Russian Federation, Slovakia, Taiwan, Ukraine
-
Chinese Association of Geriatric ResearchCompleted
-
Ferring PharmaceuticalsCompleted
-
Nordic Life Science Pipeline Inc.United States Department of DefenseCompleted
-
Ferrer Internacional S.A.Completed
-
Boehringer IngelheimCompleted
-
Alza Corporation, DE, USACompleted
-
Northwestern UniversityNational Institutes of Health (NIH); Shirley Ryan AbilityLabRecruitingBack Pain | Chronic Pain | Chronic Low-back Pain | Opioid Dependence | Opioid Use | Pain, Chronic | Back Injuries | Opioid-use Disorder | Pain, Back | Narcotic Use | Pain;Back Low;ChronicUnited States
-
Emalex Biosciences Inc.Psyadon PharmaCompleted